← Back to patent-cliff list
SMP-3124LP
Tier C — Watch / tradeSMP-3124LP
-
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：CHEK1
Indications (approved)：Solid tumour
Regional status
US
Phase II
2024-08-14
EU
-
China
-
Japan
Phase II
2024-08-14
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of SMP-3124LP?
Approved indications include: Solid tumour.
When does the SMP-3124LP patent expire?
No public expiry year is available for SMP-3124LP yet; this page updates once verified.
How do I get a quote for SMP-3124LP intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-01